Value in Health
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
EE18 Cost-Effectiveness Analysis of the Aspergillus Galactomannan Enzyme Immunoassay in the Brazilian Public Health System.
26:S62.
2023-01-01
-
EE21 COVID-19 Premature Mortality Productivity Losses: Real World Information Analysis.
26:S63.
2023-01-01
-
EE244 Cost-Effectiveness Analysis of Liposomal Amphotericin B Versus Isavuconazole for Treating Mucormycosis in the Consolidation Phase from the Perspective of the Brazilian Unified Health System.
26:S103.
2023-01-01
-
EE28 Identifying Factors Underlying Variation in the Cost of Acetabular Labral Repair or Debridement during Hip Arthroscopy: A Time-Driven Activity-Based Costing Analysis.
26:S64.
2023-01-01
-
EE335 A Multicenter Microcosting Study for COVID-19 in Brazil.
26:S121.
2023-01-01
-
EE36 Cost-Effectiveness Analysis of Taptest and Continuous Lumbar Drainage in Comparison to Standard Care in Suspected Idiopathic Normal Pressure Hydrocephalus from the Perspective of the Brazilian Unified Health System.
26:S65-S66.
2023-01-01
-
EE422 Estimated Annual Costs for Hemophilia a Care in Brazil.
26:S136-S137.
2023-01-01
-
EE450 Assessment of the Quality of Time-Driven Activity-Based Costing (TDABC) Studies on Cardiovascular Diseases and Oncology.
26:S141.
2023-01-01
-
EE535 Economic Evaluation of Decennial Pertussis Vaccination with Tetanus, Diphtheria and Acellular Pertussis (TDAP) Vaccine in Adult Populations with Asthma or Chronic Obstructive Pulmonary Disease (COPD) in Brazil.
26:S157.
2023-01-01
-
EE551 Impacts on Prices and Expenses with Biological Medicines of the Specialized Component of Pharmaceutical Assistance after the Entry of Biosimilars within the Brazilian Public Health System.
26:S160.
2023-01-01
-
EE567 Economic Impacts of Short-Term Projections of the Judicialization of Medicines on the Expenditure and Budget for Pharmaceutical Assistance in Brazil.
26:S163.
2023-01-01
-
EE63 Cost-Hemophilia Brazil.
26:S70-S71.
2023-01-01
-
HSD114 'Value-Based Healthcare' Initiative Is like a Marathon, Not a Sprint: Achievements and Challenges in Brazil.
26:S258.
2023-01-01
-
HSD35 If Primary Prevention Is the Solution, Why Don't We Take Advantage of All Opportunities in Brazil?.
26:S244.
2023-01-01
-
HTA42 Summary of Recent Health Technology Assessments for New Cancer Pharmacological Technologies in the Brazilian Private Healthcare System.
26:S266.
2023-01-01
-
HTA60 Potential Decision Drivers for Positive Recommendations of New Cancer Therapies in the Brazilian Private Healthcare System: Analysis of Recent HTA Submissions.
26:S269-S270.
2023-01-01
-
HTA77 Training and Active Social Participation in the Incorporation of Health Technologies in the Brazilian Unified Health System.
26:S273.
2023-01-01
-
MSR81 Vaccine Rate Coverage Forecast in Brazil: Is It Possible to Keep Polio Eradicated?.
26:S292.
2023-01-01
-
MT24 Health Technologies Aimed at the Aging Population Are Not a Global Concern.
26:S301.
2023-01-01
-
MT36 Cancer Biomarkers from a Technological Perspective: Past, Present, or Future?.
26:S303.
2023-01-01
-
PCR114 Utilizing Time-Driven Activity Based Costing to Explore Variation in the Value of Hip Arthroscopy for Acetabular Labral Repair.
26:S332-S333.
2023-01-01
-
RWD25 Usage and Costs Profile of Long-Term Contraception Users at a Health Plan Operator in the Brazil.
26:S365.
2023-01-01
-
RWD33 Cardiac Implantable Electronic Device Centers? Landscape in the Brazilian Public Healthcare: A 12-Year Real World Data Analysis.
26:S366.
2023-01-01
-
Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report.
25:677-684.
2022-01-01
-
CO122 Mapping the Characteristics of Network Meta-Analyses on Antithrombotic Therapies: An Overview and Critical Appraisal.
25:S42.
2022-01-01
-
CO127 Systematic Literature Review (SRL) of Comparative Safety and Effectiveness of Hormonal LARCs.
25:S328.
2022-01-01
-
CO63 Platinum Free-Interval in Patients With Ovarian Cancer Across an Argentinian Database: OCEANIA Real-World Study.
25:S29.
2022-01-01
-
EE176 Cost-Effectiveness of Etonogestrel Subdermal Contraceptive Implant (ESI) Compared to Levonorgestrel Intrauterine Device (LNG-IUD) Reimbursed on the Brazilian Private Health Insurance and Plans.
25:S368.
2022-01-01
-
EE240 Estimating the COVID-19 Cost-of-Illness Associated with Comorbidities in a Brazilian Public Hospital.
25:S381.
2022-01-01
-
EE415 Spatial Cost-Efficiency Analysis on the Separability Condition of COVID-19 Potential Determinants.
25:S416.
2022-01-01
-
EE429 Cost-Effectiveness and Budget Impact Analyses of Enzalutamide for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer in Mexico.
25:S139-S140.
2022-01-01
-
EE574 Cemiplimab and Pembrolizumab for Advanced Non-Small Cell Lung Cancer With PD-L1 ≥ 50%: Number Needed to Treat and Cost of Preventing an Event in the Brazilian Private Healthcare System Perspective.
25:S168-S169.
2022-01-01
-
EE76 Budget Analysis of Etonogestrel Subdermal Contraceptive Implant (ESI) Compared to Levonorgestrel Intrauterine Device (LNG-IUD) Reimbursed on the Brazilian Private Health Insurance and Plans.
25:S349-S350.
2022-01-01
-
EPH111 Causes of Medication Administration Errors in a University Hospital in Brazil.
25:S212.
2022-01-01
-
EPH50 Characterization of Clinical Features and Treatment of Non-Small Cell Lung Cancer (NSCLC) STAGE III and IV in Brazil- a Retrospective DATA-Base Study.
25:S443-S444.
2022-01-01
-
Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review.
1:1-1056.
2022-01-01
-
HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil.
25:S479.
2022-01-01
-
HSD110 JAV-Raras: Comparative Analysis of Patient?s Costs According to Clinical and Therapeutic Protocol (PCDT) and Current Clinical Practice for Osteogenesis Imperfecta (OI) in Brazilian Public Healthcare System.
25:S499.
2022-01-01
-
HTA56 COVID-19 from the Perspective of Intellectual Property.
25:S514.
2022-01-01
-
HTA89 Androgen Receptor Inhibitors for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer.
25:S313.
2022-01-01
-
P16 Antineoplastic Agents in Ovarian Cancer Treatment Using Argentinian Real-World Data: OCEANIA Study.
25:S4.
2022-01-01
-
PCR112 JAV-Raras: Health-Related Quality of Life (HRQOL) in Children and Adolescents with Osteogenesis Imperfecta (OI) in Brazil: A Cross-Sectional Study Using PEDSQLTM.
25:S562.
2022-01-01
-
PCR78 JAV-Raras: Health-Related Quality of Life (HRQOL) in Adults with Osteogenesis Imperfecta (OI) in Brazil: A Cross-Sectional Study Using EQ-5D.
25:S555.
2022-01-01
-
PCR95 JAV-Raras: Assessing and Communicating Value of Care with Patient-Centered Outcomes and Time-Driven Activity-Based Costing Method: Analysis of Osteogenesis Imperfecta in Brazilian Public Healthcare System.
25:S558.
2022-01-01
-
POSA261 Systematic Review with Network Meta-Analysis and Multicriteria Acceptability Analyses on the Effects of Systemic Antifungal Agents for Candidemia.
25:S170-S171.
2022-01-01
-
POSA75 Systematic Review of Economic Evaluations on Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer.
25:S48.
2022-01-01
-
POSB254 Mechanical Thrombectomy for Acute Ischemic Stroke: Systematic Review and Meta-Analysis.
25:S176.
2022-01-01
-
POSB422 Machine Learning-Based Virtual Screening, Molecular Docking and Drug-Likeness to Discover New Inhibitors of the Glycoprotein Spike (S1) of SARS-CoV-2.
25:S274.
2022-01-01
-
RWD155 Index Date Validation in OCEANIA a Real-World Database Study - The Importance of Looking Back.
25:S479-S480.
2022-01-01
-
Regulatory Journey on Vaccination Against COVID-19 in Brazil.
25:S479.
2022-01-01
-
PCV50 Automatic Classification of Electronic Health Records for a Value-Based Program through Machine Learning.
24:S76.
2021-01-01
-
PMU44 Quality of Life and Costs of a Telemedicine Service for Ophthalmologic Diagnoses.
24:S152.
2021-01-01
-
PND21 A Tool Proposal For Measuring Costs Using Time-Driven Activity-Based Costing For The Ischemic Stroke Care Pathway.
24:S162.
2021-01-01
-
PNS13 Comparative Network Efficiency Analysis of Brazil Response to COVID-19 at State Level.
24:S175-S175.
2021-01-01
-
PRS26 Comparison of Guidelines on Diagnostic Criteria and Recommended Treatment Pathways for COPD Patients in Latin America Â- A Systematic Review.
24:S217.
2021-01-01
-
PUK4 General Practitioner Utilization and Costs of Chronic Kidney Disease According to the 2012 KDIGO CKD Classification: A Report from the DISCOVER CKD Retrospective Cohort.
24:S234.
2021-01-01
-
Strategies, Ministers of Health and new regulations: did we win or were we won by the COVID-19 pandemic in Brazil?.
24:S115.
2021-01-01
-
Advances in Value-Based Healthcare by the Application of Time-Driven Activity-Based Costing for Inpatient Management: A Systematic Review.
1:01-823.
2020-01-01
-
Avanços na Saúde Baseada em Valores pela Aplicação de Custeio Baseado em Atividades Orientado a Tempo para Gerenciamento de Pacientes Internos: Uma Revisão Sistemática.
23:812-823.
2020-01-01
-
Effects of Lean Healthcare on Patient Flow: A Systematic Review.
23:1.
2020-01-01
-
HEALTH COST ANALYSIS: WEIGHTINESS OF THE INTERACTION BETWEEN POPULATION SEX AND AGE.
23:S313-S314.
2020-01-01
-
HEALTH PLAN PAID COST DRIVERS IN SANTA CATARINA, SOUTHERN BRAZIL.
23:S289-S290.
2020-01-01
-
Health-Related Quality of Life in Neurological Disorders Most Commonly Associated With Zika-Virus Infection: A Systematic Review.
23:969-976.
2020-01-01
-
Machine Learning Improves the Identification of Individuals With Higher Morbidity and Avoidable Health Costs After Acute Coronary Syndromes.
23:1570-1579.
2020-01-01
-
PBI14 TRASTUZUMAB BIOSIMILAR FOR BREAST CANCER TREATMENT IN BRAZILIAN PATIENTS: A BUDGET IMPACT ANALYSIS TO HELP DECISION MAKERS PROVIDE BETTER ACCESS.
23:S16.
2020-01-01
-
PBI17 Cost-Efectiveness Analysis of Biological Agents to Moderate to Severe Plaque Psoriasis Treatmente from the Brazilian Public Health System Perspective.
23:S413.
2020-01-01
-
PBI18 BIOLOGIC THERAPIES FOR MODERATE-TO-SEVERE PSORIASIS: COST PER RESPONDER ANALYSIS CONSIDERING PRIVATE HEALTHCARE SYSTEM IN BRAZIL.
23:S17-s17.
2020-01-01
-
PBI26 RAPID REVIEW OF TRASTUZUMAB BIOSIMILARS COMPARED TO REFERENCE TRASTUZUMAB FOR BREAST CANCER TREATMENT IN NAIVE PATIENTS.
23:S18.
2020-01-01
-
PCN101 Budget IMPACT Analysis of Treatment-Free Remission (TFR) of Nilotinib Therapy in Chronic Myeloid Leukemia (CML) Patients in the Brazilian Private Healthcare System (BPHS).
23:S440.
2020-01-01
-
PCN187 REGIONAL INEQUALITIES IN CERVICAL CANCER SURVIVAL IN MINAS GERAIS, BRAZIL.
23:S56.
2020-01-01
-
PCN243 ARE THE COSTS OF TREATING ADVANCED CANCER RISING EXPONENTIALLY? NOT FOR MELANOMA....
23:S65.
2020-01-01
-
PCN331 Hospitalizations and Associated Costs for Ovarian Cancer in Brazil.
23:S481.
2020-01-01
-
PCN351 Ovarian Cancer Mortality in Brazil 2008-2018.
23:S485.
2020-01-01
-
PCN72 THE REAL COST OF BONE MARROW TRANSPLANTATION: AN APPLICATION USING TIME-DRIVEN ACTIVITY-BASED COSTING IN BRAZIL.
23:S36.
2020-01-01
-
PCV18 IMPACT IN HOSPITALIZATION COSTS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN COLOMBIA: A PROPENSITY SCORE MATCHING MODEL.
23:S93.
2020-01-01
-
PCV73 COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS WITH MULTICRITERIA DECISION ANALYSIS.
23:S104.
2020-01-01
-
PDB64 THERAPEUTIC INERTIA IN THE TREAMENT OF PATIENTS WITH TYPE 2 DIABETES IN A CARDIOVASCULAR RISK MANAGEMENT COHORT FROM THE CARIBBEAN REGION OF COLOMBIA.
23:S120.
2020-01-01
-
PGI18 COST-EFFECTIVENESS OF BIOLOGICS FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN BRAZIL.
23:S146.
2020-01-01
-
PIH11 OUT-OF-POCKET HEALTH EXPENDITURES RELATED TO PRENATAL CARE: EVIDENCE FROM COLOMBIA, 2018.
23:S153.
2020-01-01
-
PIH61 ASSEMBLING EVIDENCE ABOUT THE USEFULNESS OF HARMONIC SCALPEL IN PEDIATRIC LAPAROSCOPIC FUNDOPLICATION.
23:S163.
2020-01-01
-
PIN13 ESTIMATING THE IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN ALL HPV 6/11/16/18 -RELATED DISEASES IN COLOMBIA.
23:S170-S171.
2020-01-01
-
PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL.
23:S174.
2020-01-01
-
PIN79 VACCINATION COVERAGE RATE: WHAT CAN WE EXPECT FROM BRAZIL?.
23:S181-S182.
2020-01-01
-
PMD37 LATERAL FLOW URINE LIPOARABINOMANNAN ASSAY FOR DIAGNOSIS OF ACTIVE TUBERCULOSIS IN PEOPLE LIVING WITH HIV: A SYSTEMATIC REVIEW AND META-ANALYSIS.
23:S195.
2020-01-01
-
PMS11 MEDICAL RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS IN A COMPREHENSIVE RHEUMATOLOGICAL CENTER IN COLOMBIA.
23:S216.
2020-01-01
-
PMS15 HEALTH CARE RESOURCE UTILIZATION IN PATIENTS WITH SPONDYLOARTHRITIS: A SINGLE SETTING ANALYSIS IN COLOMBIA.
23:S217.
2020-01-01
-
PMS38 Tofacitinib for the Treatment of Adult Patients with Moderate to Severe ACTIVE Psoriatic Arthritis Intolerant or with Therapeutic Failure to Synthetic or Biological Disease-Modifying Drugs.
23:S599.
2020-01-01
-
PMU1 PROPOFOL VERSUS MIDAZOLAM FOR SEDATION IN ADULT PATIENTS IN INTENSIVE CARE UNIT (ICU): A META-ANALYSIS.
23:S233-S233.
2020-01-01
-
PMU102 PERCEPTIONS OF THE APPROPRIATENESS OF CARE IN ADULT INTENSIVE CARE UNITS AT A BRAZILIAN TERTIARY ACADEMIC MEDICAL CENTER.
23:S252.
2020-01-01
-
PMU57 REGULATORY JOURNEY OVER TIME: A SYSTEMATIC MAPPING OF THE -FARMÁCIA POPULAR? PROGRAM.
23:S243.
2020-01-01
-
PMU7 Efficiency-Based Protocols for BEDS Evacuation during the COVID-19 Pandemic.
23:S604.
2020-01-01
-
PMU73 ACCESS TO MEDICINES FOR CHRONIC DISEASES IN BRAZIL: A META-NARRATIVE REVIEW OF THE `FARMÁCIA POPULAR? PROGRAM.
23:S246.
2020-01-01
-
PNS1 THE DEVELOPMENT OF A FRAMEWORK TO EVALUATE OUTCOMES WITHIN REAL-TIME DATA FROM ELECTRONIC MEDICAL RECORDS (EMR)..
23:S284.
2020-01-01
-
PNS108 DEADOPTION OF ROUTINE CHEST X-RAYS IN THE ICU: A BRAZILIAN CHOOSING WISELY EXPERIENCE.
23:S303-S304.
2020-01-01
-
PNS138 MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR A BRAZILIAN HOSPITAL BASED HEALTH TECHNOLOGY ASSESSMENT UNIT.
23:S309-S310.
2020-01-01
-
PNS178 ISPOR 2019 TOP 10 HEOR TRENDS: BRAZILIAN DECISION MAKERS' PERSPECTIVE.
23:S316.
2020-01-01
-
PNS185 DO BRAZILIAN HEALTH INSTITUTIONS DELIVER QUALITY SERVICES?.
23:S318.
2020-01-01
-
PNS2 FLUID BALANCE OR BODY WEIGHT CHANGES AS ROUTINE NURSING ACTIVITY: IS THERE A FAVORITE?.
23:S284.
2020-01-01
-
PNS29 THE USE OF PROPOFOL FOR SEDATION IN CRITICALLY ILL ADULT ICU PATIENTS: COST-EFFECTIVENESS MODEL.
23:S288-S289.
2020-01-01
-
PNS31 OUT-OF-POCKET HEALTH EXPENDITURES IN COLOMBIA: A SYSTEMATIC REVIEW.
23:S289.
2020-01-01
-
PNS44 THE USE OF METHODS TO EVALUATE OVERHEAD COSTS AND CAPACITY RATES IN TDABC STUDIES.
23:S292.
2020-01-01
-
PNS67 TOWARDS THE DEVELOPMENT OF MANAGED ENTRY AGREEMENTS GUIDELINES FOR HEALTH TECHNOLOGIES IN BRAZIL.
23:S295.
2020-01-01
-
PRS22 Exacerbation-Related Costs and Health Resource Use in COPD Patients in the Brazilian Private Healthcare System.
23:S720.
2020-01-01
-
PRS57 Treatment Profile of COPD Patients in the Hospital Italiano, Argentina: Preliminary Analysis.
23:S727.
2020-01-01
-
PRS69 DIRECT MEDICAL COSTS OF SEVERE ASTHMA IN TWO COLOMBIAN REFERENCE CENTERS.
23:S361.
2020-01-01
-
PSY34 What Do Public DATA Sources Tell US about Systemic LUPUS Erythematosus in Brazil?.
23:S749.
2020-01-01
tem uma área de assunto
publisher
is open access
-
False
invalid format
is in DOAJ
-
False
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S678965
International Standard Serial Number (ISSN)